GAS2L3 and glioblastoma: Moreover, GAS2L3 DNA hypomethylation at specific sites (such as cg13069247, cg16653538, cg12203636, etc.)was associated with poor clinical outcomes for LGG (Figure S6), but not GBM (Figure S7).